Table 1 Clinico-pathological features of patients involved in the study
Items | Lung cancer (N = 110) | Benign lung disease (N = 110) | Healthy individuals (N = 110) |
|---|---|---|---|
Gender | |||
Male | 51 (46.3%) | 64 (58.2%) | 63 (57.2%) |
Female | 59 (53.7%) | 46 (41.8%) | 47 (42.8%) |
Ages | |||
≤ 60 | 57 (51.8%) | 50 (45.5%) | 51 (46.4%) |
> 60 | 53 (48.2%) | 60 (54.5%) | 59 (53.6%) |
Smoking | |||
No | 63 (57.2%) | 71 (64.5%) | 70 (63.6%) |
Yes | 47 (48.8%) | 39 (35.5%) | 40 (36.4%) |
Histology | |||
LSCC | 62 (56.4%) | ||
LAC | 48 (43.6%) | ||
Differentiation degree | |||
Poorly differentiated | 34 (30.9%) | ||
Moderately differentiated | 42 (38.2%) | ||
Well differentiated | 34 (30.9%) | ||
Lymphatic metastasis | |||
N0–N1 | 37 (33.7%) | ||
N2–N3 | 73 (66.3%) | ||
Clinical staging | |||
IA–IIB | 52 (47.2%) | ||
IIIA–IV | 58 (52.8%) |